Tahithromos’s Frontline FRO Stock Holding History

Tahithromos’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-172,624	Closed	-$1.93M	–	19
2015 Q1	$1.93M	Buy	+172,624	New	+$2.41M	0.9%	29

Other funds holding FRO

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

OAMG

Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tahithromos's FRO Position: Q2 2015 in Review

Tahithromos sold out of Frontline (FRO) in Q2 2015, closing a stake of 172,624 shares — an estimated $1.93M sold.

Tahithromos first reported a position in FRO in Q1 2015 and held it in 1 quarter. The position peaked at $1.93M in Q1 2015. 110 funds tracked by Wall St. Rank hold FRO as of Q2 2015.

Tahithromos reported no remaining Frontline position as of Q2 2015 after selling out during the quarter.
Tahithromos sold 172,624 Frontline shares in Q2 2015, an estimated $1.93M.
Tahithromos first reported a position in Frontline in Q1 2015 and held it in 1 quarter.
Tahithromos's Frontline position peaked at $1.93M in Q1 2015.
110 funds tracked by Wall St. Rank held Frontline as of Q2 2015.

Based on Tahithromos's 13F filing for Q2 2015, filed 29 Jul 2015.